Oct 28, 2020
Please see attached a press release from Paragon Health regarding UK-manufactured PPE supplies.
Oct 16, 2020
BIVDA has commented on the Prime Minister’s statement today declaring that the United Kingdom must prepare for a ‘No Deal’ scenario as talks on an agreement stall. Chief Executive Doris-Ann Williams said; “It is concerning to hear the Prime Minister talking of no deal. The smooth import and export of IVD devices is critical to patient care and any potential impact of delays at our ports and airports would impact the most vulnerable. There is sti...
Oct 05, 2020
BIVDA Comments on Chancellor’s Speech to Conservative Party Conference BIVDA Chief Executive Doris-Ann Williams has commented on Chancellor Rishi Sunak’s speech to the Conservative Party Conference. “While the Chancellor’s speech was light on policy, we recognise that the Government has committed to doing what is necessary to support the economy and health service during what will be a difficult winter. A thriving British IVD industry will be crucial for both tr...
Oct 02, 2020
BIVDA welcomes publication of NHS England diagnostics report. BIVDA has warmly welcomed the publication of ‘Diagnostics: Recovery and Renewal’, a major review of diagnostic services by NHS England. One of the main takeaways from the review is the recommendation for the creation of Community Diagnostic Hubs (CHDs) across the country, away from hospitals, which would act as ‘one stop shops’ so that patients can receive life-saving checks...
Sep 29, 2020
BIVDA Comments on NHS Confederation ‘NHS Reset’ Report The NHS Confederation report focusses on the policy levers needed to put the NHS back onto a secure footing in the months ahead. It aims to: recognise both the sacrifice and achievements of the health and care sector’s response to COVID-19, including the major innovations that have been delivered at pace. rebuild local service provision to meet the physical, mental and social needs of communities affect...
Sep 23, 2020
BIVDA Press Release – For Immediate Release --- BIVDA IVD Market Audit Results Show COVID-19 Impact Report shows substantial impact of COVID-19 pandemic on other diagnostic tests Some diagnostic revenues down by as much as 90% COVID-19 revenues skyrocket The BIVDA Market Audit Report for the first half of 2020 has been published to participants. Twenty seven companies submitted revenue data which has been consolidated into a detailed report on the market size an...
Sep 16, 2020
Press Release – BIVDA Calls for Diagnostics Sector Support in Spending Review Submission For Immediate Release ---- The British In-Vitro Diagnostics Association has called on the Chancellor, Rishi Sunak, to put support for the UK IVD industry front of centre of the forthcoming Comprehensive Spending Review. As we begin to recover from the COVID-19 pandemic and look ahead to future health challenges, a strong, efficient and well supported IVD industry will be critical if the ...
Sep 01, 2020
For immediate releaseBIVDA joins call to urge Prime Minister to protect charity research BIVDA has joined over 30 top pharmaceutical, IVD and health tech bodies who have signed an open letter to the Prime Minister urging Government to provide financial support for medical research charities. The Life Sciences-Charity Partnership Fund, developed by the Association of Medical Research Charities (AMRC), has support from the likes of AstraZeneca, Roche and Eli Lilly. All are calling on Government to...
Aug 26, 2020
FOR IMMEDIATE RELEASE BIVDA Joins key DIT Trade Advisory Group on Life Sciences International Trade Secretary Liz Truss has today launched 11 new trade advisory groups (TAGs), as part of a major new business engagement drive designed to support the UK’s ambitious trade negotiations. As trade talks with Japan, the US, Australia and New Zealand intensify, the Trade Secretary is stepping up engagement with key industries across Britain, including life sciences, farming, manufacturin...
Jul 30, 2020
The COVID-19 rapid antibody test, developed by Abingdon Health, the medical device manufacturer leading the UK-Rapid Test Consortium (UK-RTC), has received its CE mark. This means it is approved for professional use in the UK and EU.